Julio Benedicto
Sales & Marketing at GENSIGHT BIOLOGICS S.A.
Network origin in Julio Benedicto first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 29 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Julio Benedicto via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Biologics Consulting Group, Inc.
Biologics Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Biologics Consulting Group, Inc. provides regulatory and product development advisory services for drugs and device products. It specializes in the preparation and review of CBER, CDER and CDRH regulatory applications, facility inspection, process validation packages, and electronic submissions. The company was founded by James G. Kenimer in 1993 and is headquartered in Alexandria, VA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Biotie Therapies AG
Biotie Therapies AG Pharmaceuticals: MajorHealth Technology Part of Acorda Therapeutics, Inc., Biotie Therapies AG is a holding Swiss company focused on developing drugs for the treatment of psychiatry and neurology diseases. The company is based in Zurich, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
REGENXBIO INC. | Pharmaceuticals: Major | General Counsel | |
Wayne State University (Michigan) | College/University | Undergraduate Degree | |
BAVARIAN NORDIC A/S | Pharmaceuticals: Major | General Counsel | |
Abingworth LLP
Abingworth LLP Investment ManagersFinance Abingworth LLP (Abingworth) is a venture capital firm founded in the year 1973 Peter Dickson and Anthony Montagu. The firm headquartered in London and additional offices in San Francisco and Boston. Abingworth LLP became part of The Carlyle Group Inc. (NASDAQ: CG) on 3rd August 2022. | Investment Managers | Consultant / Advisor Private Equity Investor Private Equity Investor | |
Sofinnova Partners SAS
Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Investment Managers | Corporate Officer/Principal Private Equity Investor | |
University of Cambridge | College/University | Corporate Officer/Principal Undergraduate Degree | |
The University of Chicago | College/University | Doctorate Degree | |
Suffolk University | College/University | Undergraduate Degree | |
Groupe Grimaud La Corbière SA
Groupe Grimaud La Corbière SA BiotechnologyHealth Technology Groupe Grimaud La Corbière SA specializes in biopharmaceutical and animal genetic solutions. It operates under two segments: Genetic Selection and sale of animal breeders such as broiler, and layer chickens, pigs, ducks, guinea, fowl, rabbits and pigeons; while Biopharmacy serves human and animal health such as vaccines, pharmaceutical proteins and serums for specific pathogen. The company was founded in 1966 and is headquartered in Roussay, France. | Biotechnology | Director/Board Member | |
DBV TECHNOLOGIES | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
AM-Pharma Holding BV
AM-Pharma Holding BV Pharmaceuticals: MajorHealth Technology AM-Pharma Holding BV operates as a financial holding company with interests in the bio-medical sector. The company was founded by Rudd Brands and is headquartered in Bunnik, Netherlands. | Pharmaceuticals: Major | Director/Board Member | |
Katholieke Universiteit Leuven | College/University | Graduate Degree | |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | General Government | Corporate Officer/Principal | |
Icahn School of Medicine at Mount Sinai | College/University | Doctorate Degree | |
Novasep Holding SAS
Novasep Holding SAS Chemicals: Major DiversifiedProcess Industries Novasep Holding SAS provides manufacturing solutions for the life science industries. Its products include agrochemicals fine chemicals and food ingredients. The company was founded by Roger-Marc Nicoud in 1995 and is headquartered in Lyon, France. | Chemicals: Major Diversified | Director/Board Member | |
Aprea Therapeutics AB
Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Director/Board Member | |
RAPTOR PHARMACEUTICAL CORP | Pharmaceuticals: Major | Corporate Officer/Principal | |
Anabasis SRL
Anabasis SRL Miscellaneous Commercial ServicesCommercial Services Part of Dompé SpA, Anabasis SRL provides biopharmaceutical research and development services. The company is based in Milan, Italy. The Italian company was founded by Francesco Sinigaglia. Anabasis was acquired by Dompé SpA on February 27, 2012. | Miscellaneous Commercial Services | Director/Board Member | |
Devialet SA
Devialet SA Electronics/AppliancesConsumer Durables Devialet SA manufactures audio integrated amplifiers. Its products include Devialet 120, Devialet 400, Devialet 200, and Devialet 800. The firm also offers home audio amplification system called Devialet ensemble, D-Premier, and Devialet 250. The company was founded by Pierre-Emmanuel Calmel, Mathias Moronvalle, Emmanuel Nardin, and Quentin Sannié in 2007 and is headquartered in Paris, France. | Electronics/Appliances | Director/Board Member | |
VALNEVA | Biotechnology | Director/Board Member | |
PIXIUM VISION | Medical Specialties | Founder Director/Board Member | |
Raptor Pharmaceuticals Europe BV
Raptor Pharmaceuticals Europe BV Miscellaneous Commercial ServicesCommercial Services Part of Amgen, Inc., Raptor Pharmaceuticals Europe BV is a Dutch company that engages in research and experimental development in other physical and natural sciences. The company is based in Louveciennes, the Netherlands. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Doctolib SAS
Doctolib SAS Packaged SoftwareTechnology Services Doctolib SAS develops software for the health industry. This software improves the efficiency of hospitals and reinforces the cooperation with colleagues. The company was founded by Ivan Schneider, Jessy Bernal, and Stanislas Niox-Chateau on August 5, 2013 and is headquartered in Levallois-Perret, France. | Packaged Software | Director/Board Member | |
PIQUR Therapeutics AG
PIQUR Therapeutics AG Pharmaceuticals: OtherHealth Technology PIQUR Therapeutics AG engages in development of anti-cancer drugs based on the inhibition. Its products include PQR309, PQR620 and PQR5xx. The company was founded by Bernd Giese, Vladimir Cmiljanovic, Andreas Emmenegger, Ralf Rosenow and Matthias Wymann in August 2011 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Other | Director/Board Member | |
American Society of Gene & Cell Therapy
American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services The American Society of Gene & Cell Therapy is a medical and professional organization that represents researchers and scientists devoted to the discovery of gene and cell therapies. The American company was founded by Mark A. Kay. | Miscellaneous Commercial Services | Director/Board Member | |
Mosaic Biomedicals SL
Mosaic Biomedicals SL Hospital/Nursing ManagementHealth Services Mosaic Biomedicals SL develops personalized cancer treatments. It is engaged in the realization and development of scientific and technical research projects in the field of oncological and tumor diseases. The company was founded by Joan Seoane, Judit Anido Folgueira and José Baselga on April 19, 2013 and is headquartered in Barcelona, Spain. | Hospital/Nursing Management | Director/Board Member | |
Bamboo Therapeutics, Inc.
Bamboo Therapeutics, Inc. BiotechnologyHealth Technology Bamboo Therapeutics, Inc. develops gene therapy products for central nervous system and neuromuscular diseases. Its therapeutic platform is based on the use of Adeno-associated virus as a gene therapy vehicle. The company’s proprietary technologies include chimeric vectors, self-complementary vectors, and dual glycan receptor. It focuses on the treatment of Duchenne muscular dystrophy, giant axonal neuropathy, Friedreich ataxia, and Canavan disease. Bamboo Therapeutics was founded by Richard Jude Samulski, Sheila A. Mikhail, Josh Grieger, Xiao Xiao, and Paola Leone in December 2014 and is headquartered in Chapel Hill, NC. | Biotechnology | General Counsel | |
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Gammadelta Therapeutics Ltd.
Gammadelta Therapeutics Ltd. BiotechnologyHealth Technology Gammadelta Therapeutics Ltd. is developing the potential of gamma delta (?d) cells to create improved immunotherapy of cancer and other serious diseases. The company was founded by Raj Mehta in 2016 and is headquartered in London, the United Kingdom. | Biotechnology | Chairman Chief Tech/Sci/R&D Officer | |
Cornovum SASU
Cornovum SASU Financial ConglomeratesFinance Cornovum SASU is an investment holding French company. The company is based in Paris, France. The company was founded in 2015. The CEO is Maïlys Ferrère. | Financial Conglomerates | Chief Executive Officer | |
Versant Ventures (Switzerland) GmbH | Investment Managers | Private Equity Investor | |
StrideBio, Inc.
StrideBio, Inc. BiotechnologyHealth Technology Stridebio, Inc. focuses on creating and developing novel adeno-associated viral vector technologies. The company was founded by Aravind Asokan, Mavis Agbandje-McKenna and Patrick Ritschel and is headquartered in Durham, NC. | Biotechnology | Corporate Officer/Principal | |
LAVA THERAPEUTICS N.V. | Biotechnology | Director/Board Member | |
X4 PHARMACEUTICALS, INC. | Biotechnology | Chairman Director/Board Member | |
Standards Coordinating Body | Director/Board Member | ||
APREA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Adaptate Biotherapeutics Ltd.
Adaptate Biotherapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Adaptate Biotherapeutics Ltd. engages in research and experimental development on biotechnology. The company was founded on August 21, 2019 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Chairman Chief Executive Officer | |
Universite Paris Cite | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
Advanced Therapies Partners LLC | President | ||
Nouscom Srl | Miscellaneous Commercial Services | Director/Board Member Director/Board Member |
Statistics
International
United States | 21 |
France | 12 |
Switzerland | 6 |
Netherlands | 6 |
United Kingdom | 4 |
Sectoral
Health Technology | 27 |
Consumer Services | 8 |
Commercial Services | 7 |
Finance | 5 |
Government | 2 |
Operational
Director/Board Member | 108 |
Corporate Officer/Principal | 55 |
Chairman | 27 |
Independent Dir/Board Member | 25 |
Chief Tech/Sci/R&D Officer | 22 |
Most connected contacts
Insiders | |
---|---|
Bernard Gilly | 32 |
Michael Wyzga | 31 |
Barrett Katz | 23 |
Guido Magni | 23 |
Maïlys Ferrère | 21 |
Genghis Lloyd-Harris | 19 |
Cédric Moreau | 14 |
Maritza McIntyre | 14 |
Elsy Boglioli Hofman | 14 |
Peter Goodfellow | 13 |
Natalie Mount | 10 |
Philippe Motté | 8 |
Leigh Shaw | 6 |
Charlotte Corbaz | 6 |
Simone Seiter | 6 |
- Stock Market
- Insiders
- Julio Benedicto
- Company connections